 |
| |
5-Fluorouracil |
| |
Acarbose |
| |
Atracurium Besilate |
| |
Azithromycin Dihydrate |
| |
Calcium Folinate |
| |
Calcium levofolinate |
| |
Calcium levomefolate |
| |
Capecitabine |
| |
Carboplatin |
| |
Carmustine |
| |
Celecoxib |
| |
Cisatracurium Besilate |
| |
Cisplatin |
| |
Cyclophosphamide |
| |
Cyclosporin |
|
|
|
 |
 API |
| No |
English Name |
CAS NO. |
Specification |
Therapy |
| 1 |
5-Fluorouracil |
51-21-8 |
USP32 |
Oncology |
| 2 |
Acarbose |
56180-94-0 |
EP6 |
Antidiabetes |
| 3 |
Atracurium Besilate
(CEP No.:R0-CEP 2013-019-Rev 00 ) |
64228-81-5 |
BP2003 or EP7.7/BP2001 or USP35 or USP36 |
Muscle relaxants |
| 4 |
Azithromycin Dihydrate |
83905-01-5 |
USP33 |
antibiotic |
| 5 |
Calcium Folinate |
1492-18-8 |
USP32 & EP7.0 |
Oncology |
| 6 |
Calcium levofolinate |
80433-71-2 |
In-House Standard |
Oncology |
| 7 |
Calcium levomefolate |
151533-22-1 |
In-House Standard |
Oncology |
| 8 |
Capecitabine
(USDMF No.26818) |
154361-50-9 |
USP36 |
Oncology |
| 9 |
Carboplatin |
41575-94-4 |
USP34 or EP7.3 |
Oncology |
| 10 |
Carmustine |
154-93-8 |
In-House Standard |
Oncology |
| 11 |
Celecoxib |
169590-42-5 |
In-House Standard |
Anti-inflammatory |
| 12 |
Cisatracurium Besilate |
96946-42-8 |
CP2010 or according to client's requriements |
Muscle relaxants |
| 13 |
Cisplatin |
15663-27-1 |
USP34 or EP7.3 |
Oncology |
| 14 |
Cyclophosphamide |
6055-19-2 |
USP34 |
Oncology |
| 15 |
Cyclosporin |
63775-96-2 |
In-House Standard |
Immunosuppressant |
| 16 |
Cytarabine |
147-94-4 |
USP34 |
Oncology |
| 17 |
Docetaxel Anhydrous |
114977-28-5 |
In-House Standard |
Oncology |
| 18 |
Doxorubicin HCL |
25316-40-9 |
USP32 |
Oncology |
| 19 |
Entecavir |
142217-69-4 |
In-House Standard |
Anti HBV |
| 20 |
Epirubicin HCL |
56390-09-1 |
EP5 |
Oncology |
| 21 |
Etoposide |
33419-42-0 |
USP34 |
Oncology |
| 22 |
Fludarabine phosphate |
75607-67-9 |
USP31/EP6 |
Oncology |
| 23 |
Gemcitabine HCL |
122111-03-9 |
USP33 |
Oncology |
| 24 |
Glimepiride |
93479-97-1 |
USP34 |
Antidiabetes |
| 25 |
Ifosfamide |
3778-73-2 |
USP32 and EP6 |
Oncology |
| 26 |
Irinotecan HCL Trihydrate |
136572-09-3 |
In-House Standard |
Oncology |
| 27 |
Ivabradine HCL |
148849-67-6 |
In-House Standard |
Antianginal drug |
| 28 |
Leflunomide |
75706-12-6 |
USP32 |
Antiarthrophlogosis |
| 29 |
Letrozole |
112809-51-5 |
USP36 or EP7.0 |
Oncology |
| 30 |
Lomustine |
13010-47-4 |
BP2002 |
Oncology |
| 31 |
Mesna |
19767-45-4 |
EP7 |
Oncology |
| 32 |
Methotrexate |
59-05-2 |
USP34 & EP7 |
Oncology |
| 33 |
Mevastatin |
73573-88-3 |
In-house standard |
Lipid lowering drugs |
| 34 |
Milrinone |
78415-72-2 |
USP34 |
cardiotonic drug |
| 35 |
Mitomycin C |
50-07-7 |
USP34 & EP7 |
Oncology |
| 36 |
Nedaplatin |
95734-82-0 |
In-House Standard |
Oncology |
| 37 |
Noradrenaline Bitartrate |
69815-49-2 |
USP31 or EP5 |
Adrenoceptor agonists |
| 38 |
Oxaliplatin |
61825-94-3 |
EP7.3 |
Oncology |
| 39 |
Paclitaxel |
33069-62-4 |
USP32 |
Oncology |
| 40 |
Pancuronium Bromide |
15500-66-0 |
EP6 |
Muscle relaxants |
| 41 |
Ribavirin |
36791-04-5 |
USP31 |
Anti-Virus |
| 42 |
Rocuronium Bromide |
119302-91-9 |
EP6 |
Muscle relaxants |
| 43 |
Satraplatin |
129580-63-8 |
In-House Standard |
Oncology |
| 44 |
Terazosin HCL Dihydrate |
70024-40-7 |
In-House Standard |
Anti-HBP |
| 45 |
Tolterodine L-Tartrate |
124937-52-6 |
In-House Standard |
Anti-incontinence |
| 46 |
Topiramate |
97240-79-4 |
In-House Standard |
Antiepileptic drugs |
| 47 |
Tropicamide |
1508-75-4 |
USP33 |
Eyedrop |
| 48 |
Vinblastine Sulphate |
143-67-9 |
USP31 |
Oncology |
| 49 |
Vincristine Sulphate |
2068-78-2 |
USP31 |
Oncology |
| 50 |
Vindesine sulfate |
59917-39-4 |
In-House Standard |
Oncology |
| 51 |
Vinorelbine Tartrate |
125317-39-7 |
USP33 or EP6 |
Oncology |
| 52 |
Bendamustin HCL |
3543-75-7 |
In-house standard |
-- |
|
|
|
|
 |
|
